Australia markets closed

RGEN Jun 2024 130.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
5.60-0.40 (-6.67%)
As of 12:09PM EDT. Market open.
Full screen
Previous close6.00
Open5.60
Bid5.30
Ask6.10
Strike130.00
Expiry date2024-06-21
Day's range5.60 - 5.60
Contract rangeN/A
Volume1
Open interest10
  • Zacks

    Repligen (RGEN) Promotes CCO, Shares Fall on Leadership Change

    Repligen (RGEN) appoints Olivier Loeillot as the company's new president and chief executive officer, effective from Sep 1, 2024. Stock falls on the news.

  • GlobeNewswire

    Repligen Announces CEO Transition Plan

    Tony J. Hunt to Transition from Chief Executive Officer to Executive Chair, Olivier Loeillot Appointed to Role of President and Chief Executive Officer, Effective September 1, 2024 Tony J. Hunt Chief Executive Officer Olivier Loeillot President and Chief Commercial Officer WALTHAM, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that its Board of Directors (“Board”) has approved t

  • Zacks

    Repligen (RGEN) Down 10.9% Since Last Earnings Report: Can It Rebound?

    Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.